Terms: = Uterine cancer AND WIF1, WIF-1, 11197, ENSG00000156076
13 results:
1. wif1 promoter hypermethylation induce endometrial carcinogenesis through the Wnt/β-catenin signaling pathway.
Zhang B; Ji J; Hu M; Zhou X; Nie Q; Xu H; Jiang C; Fu Y; Li L
Am J Reprod Immunol; 2023 Aug; 90(2):e13743. PubMed ID: 37491917
[TBL] [Abstract] [Full Text] [Related]
2. wif1 was downregulated in cervical cancer due to promoter methylation.
Wang Y; Yuan S; Ma J; Liu H; Huang L; Zhang F; Wang X
Acta Biochim Pol; 2023 Jun; 70(2):419-423. PubMed ID: 37306343
[TBL] [Abstract] [Full Text] [Related]
3. EZH2 activates Wnt/β-catenin signaling in human uterine fibroids, which is inhibited by the natural compound methyl jasmonate.
Ali M; Stone D; Laknaur A; Yang Q; Al-Hendy A
F S Sci; 2023 Aug; 4(3):239-256. PubMed ID: 37182601
[TBL] [Abstract] [Full Text] [Related]
4. Extracellular matrix (ECM) activates β-catenin signaling in uterine fibroids.
Ko YA; Jamaluddin MFB; Adebayo M; Bajwa P; Scott RJ; Dharmarajan AM; Nahar P; Tanwar PS
Reproduction; 2018 Jan; 155(1):61-71. PubMed ID: 29066531
[TBL] [Abstract] [Full Text] [Related]
5. Hypermethylation of wif1 and its inhibitory role in the tumor growth of endometrial adenocarcinoma.
Deng X; Hou C; Wang H; Liang T; Zhu L
Mol Med Rep; 2017 Nov; 16(5):7497-7503. PubMed ID: 28944908
[TBL] [Abstract] [Full Text] [Related]
6. Putative biomarkers for cervical cancer: SNVs, methylation and expression profiles.
Cardoso MFS; Castelletti CHM; Lima-Filho JL; Martins DBG; Teixeira JAC
Mutat Res Rev Mutat Res; 2017 Jul; 773():161-173. PubMed ID: 28927526
[TBL] [Abstract] [Full Text] [Related]
7.
Liang J; Zhou H; Peng Y; Xie X; Li R; Liu Y; Xie Q; Lin Z
Biomed Res Int; 2016; 2016():4923903. PubMed ID: 27843945
[TBL] [Abstract] [Full Text] [Related]
8. Quantitative DNA methylation analysis of candidate genes in cervical cancer.
Siegel EM; Riggs BM; Delmas AL; Koch A; Hakam A; Brown KD
PLoS One; 2015; 10(3):e0122495. PubMed ID: 25826459
[TBL] [Abstract] [Full Text] [Related]
9. Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
van der Horst PH; Wang Y; Vandenput I; Kühne LC; Ewing PC; van Ijcken WF; van der Zee M; Amant F; Burger CW; Blok LJ
PLoS One; 2012; 7(1):e30840. PubMed ID: 22295114
[TBL] [Abstract] [Full Text] [Related]
10. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract] [Full Text] [Related]
11. wif1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.
Delmas AL; Riggs BM; Pardo CE; Dyer LM; Darst RP; Izumchenko EG; Monroe M; Hakam A; Kladde MP; Siegel EM; Brown KD
Carcinogenesis; 2011 Nov; 32(11):1625-33. PubMed ID: 21873353
[TBL] [Abstract] [Full Text] [Related]
12. Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.
van der Meide WF; Snellenberg S; Meijer CJ; Baalbergen A; Helmerhorst TJ; van der Sluis WB; Snijders PJ; Steenbergen RD
Gynecol Oncol; 2011 Oct; 123(1):116-22. PubMed ID: 21726894
[TBL] [Abstract] [Full Text] [Related]
13. Aneuploidy predicts outcome in patients with endometrial carcinoma and is related to lack of CDH13 hypermethylation.
Suehiro Y; Okada T; Okada T; Anno K; Okayama N; Ueno K; Hiura M; Nakamura M; Kondo T; Oga A; Kawauchi S; Hirabayashi K; Numa F; Ito T; Saito T; Sasaki K; Hinoda Y
Clin Cancer Res; 2008 Jun; 14(11):3354-61. PubMed ID: 18519763
[TBL] [Abstract] [Full Text] [Related]